CST, 9178S, Mer (348E6) Mouse Monoclonal Antibody

Monoclonal Antibody for studying Mer. Validated for Western Blotting. Available in 2 sizes. Highly specific and rigorously validated in-house, Mer (348E6) Mouse Monoclonal Antibody (CST #9178) is ready to ship. Product Usage Information Western Blotting: 1:1000 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at -20°C. Do not aliquot the antibody. For a carrier free (BSA and azide free) version of this product see product # 20912 . Protocol Available protocols: Western Blotting Specificity / Sensitivity Mer (348E6) Mouse Monoclonal Antibody detects endogenous levels of Mer proteins. This antibody does not cross-react with other receptor tyrosine kinase family members. Species Reactivity: Human Source / Purification Monoclonal antibody is produced by immunizing animals with recombinant human Mer extracellular domain produced in Sf21 cells. Background Mer tyrosine kinase belongs to a receptor tyrosine kinase family with Axl and Tyro3. This family is characterized by a common NCAM (neural adhesion molecule)-related extracellular domain and a common ligand, GAS6 (growth arrest specific protein 6). Mer protein has an apparent molecular weight of 170-210 kDa due to different glycosylation patterns generated in different cell types. Mer can be activated by dimerization and autophosphorylation through ligand binding or homophilic cell-cell interaction mediated by its NCAM-like motif (1). The downstream signaling components of activated Mer include PI3 kinase, PLCγ, and MAP kinase (2). Family members are prone to transcriptional regulation and carry out diverse functions, including the regulation of cell adhesion, migration, phagocytosis, and survival (3). Mer regulates macrophage activation, promotes apoptotic cell engulfment, and supports platelet aggregation and clot stability (4). Investigators have found that overexpression of Mer may play a cooperative role in leukemogenesis and may be an effective target for biologically based leukemia/lymphoma therapy (5). Alternate Names c-Eyk; c-mer; c-mer proto-oncogene tyrosine kinase; MER; MER proto-oncogene, tyrosine kinase; MER receptor tyrosine kinase; MERTK; MGC133349; Proto-oncogene c-Mer; Receptor tyrosine kinase MerTK; RP38; STK kinase; Tyro12; Tyrosine-protein kinase Mer Specification REACTIVITY: H SENSITIVITY: Endogenous MW (kDa): 210 Source/Isotype: Mouse IgG1